Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
vocimagene amiretrorepvec/extended release flucytosine (DB107)
i
Other names:
DB107, DB-107, DB 107, Toca 511/Toca FC, Toca511/Toca FC, Toca-511/Toca-FC, Toca 511, vocimagene amiretrorepvec-flucytosine gene therapy, ABC 511/FC
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
ApolloBio, Denovo
Drug class:
Thymidylate synthase inhibitor, Cytosine deaminase inhibitor
Related drugs:
‹
5-fluorouracil (143)
capecitabine (81)
pemetrexed (58)
gimeracil/oteracil/tegafur (7)
raltitrexed (3)
arfolitixorin (2)
fluorouracil topical (1)
NUC-3373 (1)
tegafur/uracil (1)
pemetrexed (0)
TG6002 (0)
nolatrexed (0)
doxifluridine (0)
LY01616 (0)
levoleucovorin calcium (0)
5-fluorouracil (143)
capecitabine (81)
pemetrexed (58)
gimeracil/oteracil/tegafur (7)
raltitrexed (3)
arfolitixorin (2)
fluorouracil topical (1)
NUC-3373 (1)
tegafur/uracil (1)
pemetrexed (0)
TG6002 (0)
nolatrexed (0)
doxifluridine (0)
LY01616 (0)
levoleucovorin calcium (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.